Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
QBIOTICS REPORTS 80% OBJECTIVE RESPONSE RATE IN INJECTED TUMOURS IN STAGE 1 OF PHASE IIA CLINICAL TRIAL OF TIGILANOL TIGLATE FOR SOFT TISSUE SARCOMA 2025-06-25 18:05
Academic friend or foe? Yugo research reveals how students supercharge their studies with AI 2025-06-19 05:33
Largest Australian Health Insurer to Fund Innovative PTSD Treatment Program 2025-06-18 20:00
Polus holds €425 million initial close for third CLO equity fund 2025-06-17 22:18
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx 2025-06-17 21:04
Ace Green Recycling and Enecell Announce Strategic Agreement to Advance Sustainable Battery Recycling in Australia 2025-06-16 20:00
PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL 2025-06-16 19:00
NUZ-001 Shows Promise in Zebrafish Model of Huntington's Disease 2025-06-16 19:00
SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging 2025-06-13 21:01
U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio's Lead Product (PHOX2B PC-CAR T) for the Treatment of Neuroblastoma 2025-06-13 19:35
Dazu Rock Carvings: The Last Monument of World Grotto Art 2025-06-12 23:29
Cam Model Earned Over $3.4 Million Streaming on LiveJasmin -- 3rd Edition of International Cam Model Day Celebrates a New Era of Creator Careers 2025-06-12 01:09
Uzbekistan Sees Foreign Investment Growth of over 60 per cent in 2024 2025-06-10 17:00
DISCO topline results: 64Cu-SARTATE is highly effective in detecting tumours in NET patients compared to SOC imaging. Phase III planning underway. 2025-06-05 21:01
Mérieux NutriSciences and AsureQuality Announce the Official Launch of Mérieux NutriSciences AQ (MNAQ) Joint Venture 2025-06-02 05:00
NEW THERAPY FOR CHILDREN WITH GROWTH HORMONE DEFICIENCY APPROVED IN AUSTRALIA 2025-05-30 00:01
First patient imaged in Phase III AMPLIFY trial with 64Cu-SAR-bisPSMA PET/CT 2025-05-29 21:04
Platinum Jets Officially Launches Services and Real-Time Instant Quote Tool for Private Jet Travel 2025-05-27 21:00
Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik 2025-05-27 13:00
Registrational Phase III AMPLIFY trial in biochemical recurrence of prostate cancer commences 2025-05-20 21:02
1 2 3 4 5 6 120